These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Progress, challenges, and opportunities in Francisella vaccine development. Elkins KL, Kurtz SL, De Pascalis R. Expert Rev Vaccines; 2016 Sep; 15(9):1183-96. PubMed ID: 27010448 [Abstract] [Full Text] [Related]
28. Live attenuated tularemia vaccines: recent developments and future goals. Marohn ME, Barry EM. Vaccine; 2013 Aug 02; 31(35):3485-91. PubMed ID: 23764535 [Abstract] [Full Text] [Related]
29. [The effect of tularemia vaccine on the radioresistance of white rats exposed to x-irradiation]. Zil'fian VN, Kumkumadzhian VA, Nersesian AK, Tonapetian KhA. Radiobiologiia; 1989 Aug 02; 29(1):113-6. PubMed ID: 2928478 [Abstract] [Full Text] [Related]
33. [Tularemia vaccine strain is a potential vector]. Pavlov VM, Mokrievich AN, Noskov AN, Urakov NN. Vestn Ross Akad Med Nauk; 1997 Aug 02; (6):30-2. PubMed ID: 9289276 [Abstract] [Full Text] [Related]
34. Francisella tularensis Vaccines Elicit Concurrent Protective T- and B-Cell Immune Responses in BALB/cByJ Mice. De Pascalis R, Mittereder L, Chou AY, Kennett NJ, Elkins KL. PLoS One; 2015 Aug 02; 10(5):e0126570. PubMed ID: 25973794 [Abstract] [Full Text] [Related]
35. An in vitro model system used to study adherence and invasion of Francisella tularensis live vaccine strain in nonphagocytic cells. Lindemann SR, McLendon MK, Apicella MA, Jones BD. Infect Immun; 2007 Jun 02; 75(6):3178-82. PubMed ID: 17339345 [Abstract] [Full Text] [Related]